| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
|
J Clin Oncol
|
2008
|
5.46
|
|
2
|
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
|
J Clin Oncol
|
2008
|
3.55
|
|
3
|
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo.
|
Neoplasia
|
2006
|
1.55
|
|
4
|
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
|
Cancer Res
|
2008
|
1.35
|
|
5
|
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
|
Cancer Res
|
2006
|
1.34
|
|
6
|
Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.
|
Cancer
|
2010
|
1.32
|
|
7
|
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.31
|
|
8
|
Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.
|
Am J Pathol
|
2006
|
1.26
|
|
9
|
Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form.
|
Oncogene
|
2003
|
1.22
|
|
10
|
Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts.
|
J Biol Chem
|
2004
|
1.16
|
|
11
|
Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
|
Cancer
|
2011
|
1.12
|
|
12
|
Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
|
J Interferon Cytokine Res
|
2011
|
1.07
|
|
13
|
Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck.
|
Clin Cancer Res
|
2009
|
1.07
|
|
14
|
A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
|
J Pharmacol Exp Ther
|
2006
|
1.04
|
|
15
|
Targeting mRNA stability arrests inflammatory bone loss.
|
Mol Ther
|
2008
|
1.04
|
|
16
|
Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6.
|
Clin Cancer Res
|
2013
|
0.98
|
|
17
|
Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma.
|
J Biol Chem
|
2005
|
0.94
|
|
18
|
High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.
|
Transl Oncol
|
2010
|
0.92
|
|
19
|
The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma.
|
Transl Oncol
|
2013
|
0.92
|
|
20
|
Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use.
|
Hum Gene Ther
|
2009
|
0.92
|
|
21
|
Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2010
|
0.92
|
|
22
|
Fungiform papilla pattern: EGF regulates inter-papilla lingual epithelium and decreases papilla number by means of PI3K/Akt, MEK/ERK, and p38 MAPK signaling.
|
Dev Dyn
|
2008
|
0.90
|
|
23
|
Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.
|
Cell Signal
|
2011
|
0.89
|
|
24
|
Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease.
|
J Periodontol
|
2008
|
0.88
|
|
25
|
High matrix metalloproteinase activity is a hallmark of periapical granulomas.
|
J Endod
|
2009
|
0.88
|
|
26
|
Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis.
|
Nutr Cancer
|
2011
|
0.88
|
|
27
|
Adenomatoid odontogenic tumor developing in association with an odontoma: report of a case.
|
Quintessence Int
|
2008
|
0.83
|
|
28
|
The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.
|
Mol Cancer Ther
|
2014
|
0.82
|
|
29
|
Differential expression of mitogen activating protein kinases in periodontitis.
|
J Clin Periodontol
|
2013
|
0.81
|
|
30
|
Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer.
|
Small GTPases
|
2012
|
0.81
|
|
31
|
The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion.
|
BMC Cancer
|
2010
|
0.81
|
|
32
|
Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
|
Oral Oncol
|
2012
|
0.79
|
|
33
|
Characterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging.
|
Exp Biol Med (Maywood)
|
2013
|
0.79
|
|
34
|
cAMP binding protein assay for widespread use in cell signaling studies.
|
Biotechniques
|
2002
|
0.79
|
|
35
|
Recovery of salivary epidermal growth factor in parotid saliva following parotid sparing radiation therapy: a proof-of-principle study.
|
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
|
2011
|
0.77
|
|
36
|
Implant compression necrosis: current understanding and case report.
|
J Periodontol
|
2009
|
0.77
|
|
37
|
Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens.
|
Oncoimmunology
|
2013
|
0.76
|
|
38
|
Clinical-pathological conference: case 5.
|
Head Neck Pathol
|
2010
|
0.75
|
|
39
|
Mucous membrane pemphigoid: a retrospective study.
|
J Mich Dent Assoc
|
2007
|
0.75
|
|
40
|
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
|
Nat Commun
|
2016
|
0.75
|